LA
MRNA icon

LPF Advisors’s Moderna MRNA Stock Holding History

LPF Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$210K Buy
+7,423
New +$263K 0.17% 31
2024
Q4 		– Sell
-4,196
Closed -$280K – 36
2024
Q3 		$280K Buy
4,196
+313
+8% +$28.7K 0.24% 25
2024
Q2 		$461K Buy
+3,883
New +$491K 0.43% 19

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LPF Advisors's MRNA Position: Q1 2025 in Review

LPF Advisors opened a new position in Moderna (MRNA) in Q1 2025: 7,423 shares worth $210K. The stake represents 0.17% of the portfolio and ranks #31 among its holdings. This is a return to the name: LPF Advisors previously reported a position in MRNA as recently as Q3 2024.

LPF Advisors first reported a position in MRNA in Q2 2024 and has held it in 3 quarters since. The position peaked at $461K in Q2 2024. 694 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • LPF Advisors held 7,423 shares of Moderna worth $210K as of Q1 2025.
  • Moderna was a new LPF Advisors position in Q1 2025.
  • Moderna made up 0.17% of LPF Advisors's portfolio in Q1 2025, its #31 holding.
  • LPF Advisors first reported a position in Moderna in Q2 2024 and has held it in 3 quarters since.
  • LPF Advisors's Moderna position peaked at $461K in Q2 2024.
  • 694 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on LPF Advisors's 13F filing for Q1 2025, filed 11 Apr 2025.